Athira Pharma, Inc. (ATHA)
NASDAQ: ATHA · IEX Real-Time Price · USD
1.920
-0.090 (-4.48%)
At close: Apr 25, 2024, 4:00 PM
1.970
+0.050 (2.60%)
After-hours: Apr 25, 2024, 7:28 PM EDT
Athira Pharma Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for Athira Pharma stock have an average target of 12, with a low estimate of 5.00 and a high estimate of 19. The average target predicts an increase of 525.00% from the current stock price of 1.92.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 11, 2023.
Analyst Ratings
The average analyst rating for Athira Pharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +889.58% | Aug 11, 2023 |
| Mizuho | Mizuho | Strong Buy Maintains $6 → $5 | Strong Buy | Maintains | $6 → $5 | +160.42% | May 15, 2023 |
| BTIG | BTIG | Strong Buy Maintains $33 → $10 | Strong Buy | Maintains | $33 → $10 | +420.83% | Mar 30, 2023 |
| JMP Securities | JMP Securities | Buy Reiterates $20 | Buy | Reiterates | $20 | +941.67% | Mar 24, 2023 |
| Mizuho | Mizuho | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +212.50% | Jul 7, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.30
from -3.09
EPS Next Year
-2.01
from -3.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | 14.1M | n/a | n/a |
| Avg | n/a | n/a | 6.8M | n/a | n/a |
| Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -3.16 | -0.67 | -0.37 |
| Avg | -3.30 | -2.01 | -0.55 |
| Low | -3.47 | -3.51 | -0.71 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.